Latest News and Press Releases
Want to stay updated on the latest news?
-
London and Paris, Dec. 02, 2019 (GLOBE NEWSWIRE) -- — Curium has successfully completed the acquisition of Finnish radiopharmaceuticals company MAP Medical Technologies Oy. The acquisition of MAP...
-
St. Louis MO, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Curium announced today that it intends to submit an abbreviated new drug application for a generic version of DaTscanTM (Ioflupane I 123 Injection) in...
-
St. Louis, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Curium announced today that it is implementing a new pricing model for Technescan MAG3. Curium is phasing out its pay per dose sales model, in which...
-
Paris, France and St. Louis, MO USA, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Curium, a leading global player in Nuclear medicine, and Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company...
-
St. Louis and Houston, Aug. 26, 2018 (GLOBE NEWSWIRE) -- Curium and RadioMedix Inc. announce an exclusive agreement to develop and commercialize 64Cu-Dotatate, an investigational positron emission...
-
St. Louis Missouri, May 10, 2018 (GLOBE NEWSWIRE) -- Curium, a leading nuclear medicine solutions provider, announced today its re-entry into the radiopharmaceutical Xenon Xe 133 Gas market,...
-
PARIS, 02 mai 2018 (GLOBE NEWSWIRE) -- Curium a finalisé avec succès l’acquisition des activités opérationnelles de Cyclopharma, laboratoire pharmaceutique développant et produisant des traceurs...
-
Paris, May 02, 2018 (GLOBE NEWSWIRE) -- Curium has successfully completed its previously announced acquisition of the French commercial and manufacturing operations of Cyclopharma, a leading...